Targeted B-cell therapeutics
www.ephlabio.com
Founders
Founded In
2024
Fund
Hoxton IV
Headquarters
London
Invested In
2025
Hoxton Partners
Hussein Kanji
We use analytics to understand how people use this site. No cookies are set unless you accept. Privacy policy